Denali Capital Acquisition Corp. (DECA) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 7Jul 10Nov 25Mar 2Mar 10Mar 13Mar 18Mar 23

Key dataMar 23, 2026

Open$11.43

From 52W high−12.01%

Volume3631.00

Market cap$23.41M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataMar 23, 2026

Open

$11.43

From 52W high

−12.01%

Volume

3631.00

Market cap

$23.41M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

23.3

MomentumView details →

1D Return

−3.22%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

−1.1x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

0.00%

ROA (TTM)

0.00%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

−100.00%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

−100.00%

MomentumView details →

1D Return

−3.22%

YTD Return

—

1Y Return

−5.22%

RSI (14)

23.3

vs 50D SMA

−2.35%

vs 200D SMA

−3.37%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

0.06x

Quick Ratio

0.06x

Div Yield

—

Div Rate

—

Div Growth 1Y

+7.69%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

0.00

Op. CF (TTM)

−6.05M

Latest newsMore news →

Semnur Pharmaceuticals announced a proposed $100 million private placement of newly issued common stock to iHolding Group LLP at $10.00 per share, subject to due diligence, definitive agreements, board and stockholder approvals, and regulatory approvals.76d ago

Similar companies

Berto Acquisition Corp. IIGUACW Cohen Circle Acquisition Corp. II WarrantCCIIW Horizon Space Acquisition I Corp. Ordinary SharesHSPO BEST SPAC I Acquisition Corp.BSAA Eureka Acquisition Corp Class A Ordinary ShareEURK ASPAC III Acquisition Corp.ASPC Find similar companies →

Latest newsMore news →

Semnur Pharmaceuticals announced a proposed $100 million private placement of newly issued common stock to iHolding Group LLP at $10.00 per share, subject to due diligence, definitive agreements, board and stockholder approvals, and regulatory approvals.76d ago